2007
DOI: 10.1007/s10353-007-0326-4
|View full text |Cite
|
Sign up to set email alerts
|

Course of transplant recipients treated with Ertapenem in the prophylaxis and treatment of infections: a first experience

Abstract: Ertapenem in der Infektionsprophylaxe bei OrganempfängernZusammenfassung. Grundlagen: Infektionen sind die hä ufigsten Komplikationen nach Organtransplantationen. Bakterien gehö ren zu den hä ufigsten Erregern, wobei Entwicklung von Resistenzen gegen Antibiotika Anlass zu besonderer Sorge gibt. Ertapenem, ein neues Antibiotikum der Carbapenemgruppe mit langer Halbwertszeit, wurde kü rzlich in die klinische Praxis eingefü hrt. Methodik: Zwischen Jä nner 2004 und Dezember 2004 wurden an der Innsbrucker Universit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 30 publications
0
2
0
Order By: Relevance
“…Additionally, two studies were included after reference search of the abovementioned studies. Finally, 39 studies met the present study’s inclusion criteria [ 6 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 ]. Additional information was kindly provided by the corresponding authors of two studies [ 40 , 48 ].…”
Section: Resultsmentioning
confidence: 99%
“…Additionally, two studies were included after reference search of the abovementioned studies. Finally, 39 studies met the present study’s inclusion criteria [ 6 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 ]. Additional information was kindly provided by the corresponding authors of two studies [ 40 , 48 ].…”
Section: Resultsmentioning
confidence: 99%
“…Once E. corrodens, P. melaninogenica, and Lactobacillus spp. were isolated, treatment was changed to ertapenem (1 g daily), a carbapenem that is suitable for the treatment of susceptible mixed aerobeanaerobic surgical infections [36][37][38][39]. Thus far no data are available on therapy of liver abscesses with ertapenem; however, other carbapenems have been shown to be suitable agents [40].…”
Section: Discussionmentioning
confidence: 99%